Entered Evaluable CR* CRNC** Overall Response
No. of Patients 153 119 54 36 90
Percent Response   --- 45.40% 30.20% 75.60%
*No evidence of disease on cystoscopy and a negative cytology (CR) **No evidence of disease on cystoscopy and not validated by cytology (CRNC)
Table 1: Response of Patients to TICE BCG in CIS Bladder Cancer